Word

ZOLEN

Status

Dead

Status Code

606

Status Date

Monday, June 17, 2019

Serial Number

87646718

Mark Type

4000

Filing Date

Monday, October 16, 2017

Published for Opposition

Tuesday, March 20, 2018

Abandoned Date

Monday, June 17, 2019

Trademark Owner History

Teva Pharmaceuticals USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Trademark Events

Jun 17, 2019

Abandonment Notice E-Mailed - No Use Statement Filed

Jun 17, 2019

Abandonment - No Use Statement Filed

Nov 14, 2018

Notice Of Approval Of Extension Request E-Mailed

Nov 12, 2018

Extension 1 Granted

Nov 12, 2018

Extension 1 Filed

Nov 12, 2018

Teas Extension Received

May 15, 2018

Noa E-Mailed - Sou Required From Applicant

Mar 20, 2018

Official Gazette Publication Confirmation E-Mailed

Mar 20, 2018

Published For Opposition

Feb 28, 2018

Notification Of Notice Of Publication E-Mailed

Feb 6, 2018

Approved For Pub - Principal Register

Jan 30, 2018

Teas/Email Correspondence Entered

Jan 30, 2018

Correspondence Received In Law Office

Jan 30, 2018

Teas Response To Office Action Received

Jan 23, 2018

Notification Of Non-Final Action E-Mailed

Jan 23, 2018

Non-Final Action E-Mailed

Jan 23, 2018

Non-Final Action Written

Jan 22, 2018

Assigned To Examiner

Oct 25, 2017

New Application Office Supplied Data Entered In Tram

Oct 19, 2017

New Application Entered In Tram